Oxford Biomedica plc (OTCMKTS:OXBDF – Get Free Report) shares dropped 3.3% during trading on Thursday . The company traded as low as $4.95 and last traded at $4.95. Approximately 200 shares were traded during mid-day trading, an increase of 84% from the average daily volume of 109 shares. The stock had previously closed at $5.12.
Oxford Biomedica Trading Down 3.3 %
The company has a debt-to-equity ratio of 1.48, a quick ratio of 2.07 and a current ratio of 2.35. The stock has a 50-day simple moving average of $5.27 and a two-hundred day simple moving average of $4.86.
Oxford Biomedica Company Profile
Oxford Biomedica plc, a contract development and manufacturing organization, focuses on delivering therapies to patients worldwide. Its s LentiVector platform technology is an advanced lentiviral vector based gene delivery system which is designed to overcome the safety and delivery problems associated with earlier generations of vector systems.
See Also
- Five stocks we like better than Oxford Biomedica
- What is the NASDAQ Stock Exchange?
- Cerence AI: One-Hit Wonder or Long-Term Winner After NVIDIA Pact?
- How to Calculate Retirement Income: MarketBeat’s Calculator
- UnitedHealth Group Pulls Back Into Another Healthy Opportunity
- Do Real Estate Investment Trusts Deserve a Place in Your Portfolio?
- Micron Technology: Riding the AI Wave to Long-Term Growth
Receive News & Ratings for Oxford Biomedica Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biomedica and related companies with MarketBeat.com's FREE daily email newsletter.
